VMVíctor Manuel Becerra Muñoz

Víctor Manuel Becerra Muñoz

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Víctor Manuel Becerra Muñoz has a total of 12 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Outcomes of Isolated Tricuspid Valve Surgery

    by Gemma Sánchez-Espín, Jorge Rodríguez-Capitán, Juan José Otero Forero, Víctor Manuel Becerra Muñoz, Emiliano Andrés Rodríguez Caulo, Miguel Such-Martínez, Carlos Porras-Martín, José Manuel Villaescusa-Catalán, María José Mataró-López, Aranta Guzón-Rementería, et al.

    Background: Isolated tricuspid valve surgery is a rarely performed procedure and traditionally is associated with a bad prognosis, although its clinical outcomes still are little known. The aim of this study was to assess the short- and long-term clinical outcomes obtained at our center after isolated tricuspid valve surgery as treatment for severe tricuspid regurgitation. Methods: This retrospective study included 71 consecutive patients with severe tricuspid regurgitation who underwent isolated tricuspid valve surgery between December 1996 and December 2017. Perioperative and long-term mortality, tricuspid valve reoperation, and functional class were analyzed after follow up. Results: Regarding surgery, 7% of patients received a De Vega annuloplasty, 14.1% an annuloplasty ring, 11.3% a mechanical prosthesis, and 67.6% a biological prosthesis. Perioperative mortality was 12.7% and no variable was shown to be predictive of this event. After a median follow up of 45.5 months, long-term mortality was 36.6%, and the multivariate analysis identified atrial fibrillation as the only predictor (Hazard Ratio 3.014, 95% confidence interval 1.06-8.566; P = 0.038). At the end of follow up, 63.6% of survivors had functional class I. Conclusions: Isolated tricuspid valve surgery was infrequent in our center. Perioperative mortality was high, as was long-term mortality. However, a high percentage of survivors were barely symptomatic after follow up.